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Post-Dilating Transcatheter
Heart Valves*
John G. Webb, MD, Ronald K. Binder, MD
Vancouver, British Columbia, Canada
In this issue of JACC: Cardiovascular Interventions,
Nombella-Franco and the Quebec Heart and Lung Insti-
tute (1) report their experience with balloon post-dilation in
patients with residual paravalvular aortic regurgitation after
transcatheter heart valve (THV) implantation. Paravalvular
regurgitation grade 2 was documented by transesophageal
echocardiography in approximately one-third of their 211
patients. Post-dilation reduced regurgitation by1 grade in
the majority (71%), consistent with the early experience of
our group in which paravalvular regurgitation was reduced
in 75% of patients undergoing THV post-dilation (2).
See page 499
How might post-dilation reduce paravalvular regurgita-
tion? The Quebec city group used transesophageal echocar-
diography to document an increase in stent minimum
diameter by a mean of 1.9 mm (1). Our group used
quantitative fluoroscopy to document an increase in stent
diameter by a mean of 0.9 mm (2). This, in addition to an
increase in THV circularity, likely results in improved
apposition of the sealing cuff and annular tissue (3).
Nevertheless post-dilation rates vary widely (4,5). There
are concerns that over-expansion might result in: 1) atrio-
ventricular block, periaortic hematoma, or annular rupture;
2) poor leaflet apposition with central regurgitation; or 3)
leaflet injury. Although these concerns are real, experience
has shown that post-dilation with appropriately sized,
noncompliant balloons is unlikely to result in valve injury.
Does paravalvular regurgitation matter? Severe paraval-
vular regurgitation is obviously important and must be dealt
with, although post-dilation is generally insufficient. In
contrast, mild and moderate regurgitation are well tolerated
acutely and do not increase with time. True, there is an
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Foundation.association between moderate, and even mild, paravalvular
regurgitation and increased late mortality. However, cause
and effect have not been demonstrated and there is no
evidence to date that post-dilation in the setting of mild, or
even moderate, leaks improves late survival (6–10).
Does calcification influence the severity of regurgitation?
Bulky, heavily calcified valves do predispose to paravalvular
regurgitation (11). The Quebec city group found that the
volume of calcification as determined by multidetector
computed tomography was the most important predictor of
regurgitation and the need for post-dilation. Interestingly,
calcification also predicted the likelihood of reducing regur-
gitation with post-dilation. Perhaps regurgitation in the
absence of severe calcification is more likely to be the
consequence of a THV that is just too small or implanted
too high or too low in relation to the aortic annulus?
Can post-dilation result in stroke? We know from trans-
cranial Doppler studies that cerebral microemboli are most
common at the time of THV interaction (positioning and
deployment) with the native valve (6,12,13). We have little
information about balloon dilation performed after THV
implantation. It is certainly possible that transient expansion
and recoil of a stent frame within a partially disrupted native
valve might be a particularly efficient way to generate
embolic particles.
The Quebec city group found a nonsignificant increase in
procedural major strokes (i.e., stroke with permanent dis-
ability) with post-dilation (5.1% vs. 1.3%, p  0.14).
owever, cerebrovascular events (transient ischemic events,
inor strokes without disability, and major strokes) were
arkedly increased (11.9% vs. 2.0%, p  0.006). The most
mportant predictors were calcification and post-dilation.
o what degree was post-dilation just a marker of a more
alcified valve intrinsically more likely to release embolic
aterial at the time of valve positioning or expansion? We
o not know.
What are the alternatives to post-dilation? More effective
re-dilation and, in the case of balloon expandable valves,
ore effective deployment with high pressure, appropriately
arge, noncompliant balloons might result in more complete
nd symmetrical valve expansion and a reduction in para-
alvular leaks. The competing strategy favors more conser-
ative balloon expansion to minimize the risk of embolic
troke, atrioventricular block, and annular rupture, only
ollowed by more complete post-dilation later if a paraval-
ular leak actually occurs.
Are there differences for balloon and self-expandable
alves? The rate of post-dilation with self-expanding valves
as been quite variable, with large series reporting rates of
0% to 30%, with a reduction in regurgitation reported in
ost patients (4,14–16). Post-dilation of self-expandable
alves might be associated with greater transient expansion
nd subsequent recoil than rigid balloon-expandable valves.
e do know that re-intervention (repositioning or post-
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514dilation) in the setting of a CoreValve implant (Medtronic,
Minneapolis, Minnesota) for paravalvular regurgitation is
associated with an increased stroke rate (7,8,17). Grube et
al. (17) postulated that avoiding pre-dilation before Core-
Valve implantation might result in fewer strokes. However, in
a report from this group, the post-dilation was more often
required (17%) when pre-dilation was avoided. The stroke rate
of 5% rate was comparable with other current experience (18).
To what degree valve design might alter the risk of
erebral embolization is unknown. A more occlusive sealing
uff might actually trap particulate debris; a less-distensible
ealing cuff might result in less native valve trauma and
mbolization at the time of post-dilation than a more-
istensible cuff. Newer, more effective sealing cuffs and
etter sizing might reduce paravalvular leaks and the need
or post-dilation.
For now the role of post-dilation after THV implantation
emains controversial. Will other studies bear out the
ssociation between post-dilation and embolic events? We
re sure to hear more about this over the next few years.
Reprint requests and correspondence: Dr. John Webb, St. Paul’s
Hospital, 1081 Burrard Street, Vancouver, British Columbia V6Z
1Y6, Canada. E-mail: john.webb@vch.ca.
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